Micah Young on healthcare technology
From Masimo CEO: Our healthcare investors don't know how to deal with the consumer side of the business · · CNBC Television
“There has never been a hospital grade, let alone Masimo which we are the most reliable pulse oximeter on the planet, been available for parents at home, so yeah, it should be big. It should change things and it should be great for Masimo's stockholders.”
On , Micah Young, Executive Vice President & Chief Financial Officer at MASIMO CORP, spoke about healthcare technology during Masimo CEO: Our healthcare investors don't know how to deal with the consumer side of the business on CNBC Television.
About Micah Young
Micah Young, Executive Vice President and Chief Financial Officer at Masimo, accompanied CEO Joe Kiani on a listening tour of major shareholders that led to discussions about spinning off the company's consumer health business. Kiani stated that the tour revealed a disconnect: healthcare investors were unfamiliar with the consumer side of the business, and the company sought a way to separate that segment without abandoning its broader goals for patients, people, and shareholders. Kiani also discussed the upcoming launch of a hospital-grade baby monitor with pulse oximetry, priced at approximately $200 without a camera and $300 with a camera featuring edge AI to detect if a baby has rolled face down. He described the product as the first hospital-grade pulse oximeter available for home use and said it should be significant for Masimo's stockholders. Kiani explained that Masimo's strategy involves both selling its own end-user products and working with OEMs, a "push/pull" approach he said has worked in healthcare.